Book a demo
Research & KnowledgeEvent: September 2, 2026

Gilead Sciences contributed to a publication discussing PFAS and its role in pharmaceutical manufacturing.

Published

Signal category

Research & Knowledge

Quote

This was such a fun publication to be a part of and I am proud of what we were able to contribute to this very relevant, timely and important discussion around PFAS and its role in pharmaceutical manufacturing.

Jonathan Tripp|Gilead Sciences team

Company

Industry
Biotechnology Research
Location
Foster City, US
Company size
14,911 employees

At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine. Our focus goes beyond medicines, and we also strive to remedy health inequities and break down barriers to care. We empower our people to tackle these challenges, and we’re all united in our commitment to help millions of people live healthier lives. Social Media Guidelines: https://www.gilead.com/social-media-guidelines

Customize signals for your business.

Know everything happening across the B2B world, and act on the company movements that matter to you.

© 2026 SeedOpsCompany intelligence.

SeedOps.